Physician profile
Charles S Johnson
NPI 1285636076
$2,342.08
in general payments reported to CMS, 2019-2025
31 companies · $331 in 2025
The $331 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $647 · 2020: $266 · 2021: $300 · 2022: $102 · 2023: $544 · 2024: $152 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,026.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $569.73 | 2019-2023 | |
| Genzyme Corporation | $246.76 | 2019-2025 | |
| Amgen INC. | $174.07 | 2020-2025 | Otezla, Otezla |
| Janssen Biotech, INC. | $140.38 | 2020-2023 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $139.13 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $121.24 | 2019-2023 | Ilumya, Blu-U, Odomzo |
| Kerecis Limited | $120.59 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Regeneron Healthcare Solutions, INC. | $119.28 | 2020-2025 | Libtayo |
| Genentech USA, INC. | $100.61 | 2019-2022 | |
| Leo Pharma INC. | $86.76 | 2022-2025 | Adbry, Anzupgo |
| Mentor Worldwide LLC | $79.95 | 2023-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Ucb, INC. | $50.95 | 2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $39.33 | 2025 | Zoryve |
| Convatec INC. | $30.89 | 2023 | |
| Lilly USA, LLC | $30.34 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $27.39 | 2021 | |
| Sandoz INC. | $27.05 | 2023 | Hyrimoz |
| Dusa Pharmaceuticals, INC. | $25.66 | 2019 | |
| Stryker Corporation | $25.30 | 2025 | Mako |
| Exact Sciences Corporation | $21.75 | 2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $20.27 | 2021 | |
| Aclaris Therapeutics, INC. | $19.82 | 2019 | |
| Merck Sharp & Dohme LLC | $19.51 | 2024 | Keytruda |
| Vyne Pharmaceuticals INC. | $18.82 | 2021 | |
| Organogenesis INC. | $14.97 | 2024 | Apligraf |
| Smith+Nephew, INC. | $14.56 | 2022 | |
| Galderma Laboratories, L.P. | $13.57 | 2021 | |
| Baxter Healthcare | $13.18 | 2023 | Artiss |
| Mayne Pharma Commercial LLC | $12.82 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $11.41 | 2020 | |
| Epi Health, LLC | $5.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.